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Malaria is a major health problem, accounting for up
to 500 million febrile illnesses and several million deaths
annually1–2. Malaria is endemic in India and continues to
account for almost a 1000 deaths per year since 2002.
Almost all of the mortality is accountable to Plasmodium
falciparum infection3. Vivax malaria is generally thought
as the “benign tertian malaria” and is unaccompanied by
any adverse complications. Recently few complicated
cases are being reported and the designation of benign
malaria is being challenged4. Two recent retrospective
analyses from India highlight this picture4–5. There are
few reports of neurological complications in mono-in-
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fected vivax malaria patients6. We report a case of P. vivax
infection in a patient who presented with reversible
anterior spinal cord syndrome with MRI evidence of
myelitis.
Case report
A 35 yr-old male patient was admitted to the SSKM
Hospital, Kolkata, India on 12 August 2011, with high
grade intermittent fever for two days and weakness in
both the lower limbs for one day. He developed urinary
incontinence and loss of pain sensation below mid abdo-
men. He did not report any weakness of upper limbs, res-
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piratory embarrassment or any positive sensory symp-
toms. There was no history of recent immunization or
any history suggestive of recent upper respiratory tract
infection or skin infection. The patient was haemody-
namically stable and was oriented to time, place and per-
son. There was no evidence of meningeal involvement.
Neurological examination revealed: increased muscle tone
with difficulties in passive movement and 2/5 grade
muscle power in both lower limbs; loss of pain, tempera-
ture and pressure (mild degree) sensations below the
umbilicus suggestive of lateral and ventral spinothalamic
tract involvement. Fine touch, vibration and position
senses were normal in all the dermatomes. Lower abdomi-
nal and cremasteric reflexes were lost and plantar reflexes
were bilaterally extensor. Deep tendon reflexes were brisk
in the knees and the ankles. Examination of cranial nerve
did not reveal any abnormality. Complete blood counts,
serum electrolytes, liver and renal function tests were nor-
mal. Cerebrospinal fluid (CSF) had 8 cells/ml (all lym-
phocytes), protein 64 mg/dl, and glucose 68 mg/dl. CSF
was negative for oligoclonal bands and his IgG index was
0.01. Peripheral blood smear examination showed tro-
phozoites of P. vivax. Peripheral blood thick and thin
smear examination and Plasmodium LDH test (done
twice) did not show any parasitological evidence for P.
falciparum infection.
His spinal MRI showed non-enhancing, long TR
hyperintensity at the level of T6 – T7 spine suggestive of
myelitis (Fig. 1). MRI of brain was normal. Serology for
HIV-I and II, Herpes simplex virus and enteroviruses were
negative. The patient was started a course of oral chloro-
quine followed by primaquine (30 mg once daily for 14
days). From the Day 4 of initiation of chloroquine therapy
he gradually started to regain his muscle power. By the
Day 6, his bladder complaint was diminished. After one
month follow-up he has residual lower limb hypertonia
and brisk jerks without any motor or sensory deficit.
DISCUSSION
Our patient presented with acute onset of fever with
involvement of bilateral pyramidal, and anterolateral
spinothalamic tracts without any evidence of posterior
column involvement. Demonstration of vivax parasit-
aemia and antigenemia clinched the diagnosis with fur-
ther aid from spinal MRI. Normal MRI of brain helped to
exclude multiple sclerosis. The patient suffered from vivax
malaria, complicated with reversible acute myelitis show-
ing prompt response to antimalarial therapy.
Plasmodium vivax malaria usually shows a benign
clinical course unlike P. falciparum, which often presents
features of organ dysfunction7. In falciparum malaria,
the P. falciparum erythrocyte membrane protein-1
(PfEMP-1) is important in pathogenesis8. This adhesion
molecule is anchored at RBC membrane and interacts with
a variety of host adhesion molecules causing sequestra-
tion of parasites in cerebral microcirculation with result-
ant hypoperfusion. Cytokines and chemokines like TNF,
interleukins also play major role in endothelial dysfunc-
tion. All these factors trigger widespread activation
of inflammatory process and endothelial damage9. Plas-
modium vivax is devoid of PfEMP-1 and the parasite
burden is usually less than P. falciparum10. This could
possibly explain lower rate of complication in P. vivax
malaria.
This scenario is changing rapidly with increasing
number of complications being reported in P. vivax ma-
laria. In 2009, Sharma and Khanduri4 from Delhi, India
demonstrated that thrombocytopenia, hepatic dysfunction,
renal damage, positive direct Coomb’s test and acute res-
piratory distress syndrome (ARDS) were associated with
vivax malaria, but none of the 221 vivax malaria patients
developed any neurological complications4. In another
study in India among 50 vivax malaria patients, thromb-
ocytopenia was the commonest complication followed by
liver dysfunction (62%), respiratory involvement (28%),
renal impairment (22%), shock (16%), severe anaemia
(6%), and cerebral malaria in only two cases5.
Neurological complications of P. vivax malaria are
extremely rare, though these are increasingly being re-
ported. The most common complication is cerebral ma-
laria with the hallmark of encephalopathy. Some of the
reports highlight the presence of meningeal signs in cere-
bral malaria complicating P. vivax infection in the ab-
sence of bacterial or other pathogens11. Other neurologi-
cal complications reported in vivax malaria are, periodic
paralysis12, facial diplegia13, aphasia with hemiparesis14
and Guillain-Barre syndrome15.
There are two reports of acute disseminated encepha-
lomyelitis with vivax malaria. The first one reported in a
24 yr-old Japanese male person with neurological distur-
bances two weeks after complete recovery from P. vivax
infection. MRI of the brain showed multiple high-intensity
spotty lesions in the left cerebral cortex and subcortex16. In
2011, another group from Kolkata, India reported a case of
diabetic woman with mixed P. falciparum and P. vivax in-
fections. While recovering from the episode she developed
acute onset bladder retention followed by paraparesis. MRI
of spine showed T2 hyperintensities suggestive of resolv-
ing myelitis. MRI of the brain showed multifocal and
confluent areas of demyelination mostly involving the
corpus callosum and periventricular region17. J Vector Borne Dis 50, September 2013 238
Our case emphasizes the growing spectrum of neu-
rological manifestations of vivax malaria. To the best of
our knowledge, this is probably the first case report which
shows reversible isolated spinal myelopathy with a clini-
cal picture of anterior cord syndrome occurring as a com-
plication of vivax malaria.
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